secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2024-04-17T23:59:59+00:00
Accession:  0001023024-24-000050
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharmaceuticals provides investor presentation at Piper Sandler symposium; details unavailable
--------------------------------------------------------------------------------

- Filing announces CEO Nikhil Lalwani and CFO Stephen Carey meeting investors at Piper Sandler Spring Biopharma Symposium on April 17, 2024.
- Exhibit 99.1 investor presentation furnished but not included in provided text; no financial data or guidance disclosed in filing body.
- Presentation not filed under Securities Act; standard Form 8-K items 2.02 and 7.01 invoked.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000050/0001023024-24-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000102302424000050/ani-20240417.htm
  HTML page:      https://secwatch.observer/filing/0001023024-24-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer